Subscribe to RSS
Elevated Levels of Urinary Biomarkers TIMP-2 and IGFBP-7 Predict Acute Kidney Injury in Neonates after Congenital Heart SurgeryFunding This study was supported by an institutional grant from the Kids of NYU program and also in part by an NYU CTSA grant (UL1 TR001445,) from the National Center for Advancing Translational Sciences, National Institutes of Health.
Objectives This article investigated the utility of urine biomarkers tissue inhibitor of metalloproteinase-2 (TIMP-2) and insulin-like growth factor binding protein-7 (IGFBP-7) in identifying acute kidney injury (AKI) in neonates after congenital heart surgery (CHS). TIMP-2 and IGFBP-7 are cell cycle arrest proteins detected in urine during periods of kidney stress/injury.
Methods We conducted a single-center, prospective study between September 2017 and May 2019 with neonates undergoing CHS requiring cardiopulmonary bypass (CPB). Urine samples were analyzed using NephroCheck prior to surgery and 6, 12, 24, and 96 hours post-CPB. All patients were evaluated using the Acute Kidney Injury Network (AKIN) criteria. Wilcoxon rank sum tests were used to compare the medians of the [TIMP-2*IGFBP-7] values in the AKIN negative and positive groups at each time point. Receiver operating characteristic curves were used to measure how well the [TIMP-2*IGFBP-7] values predict AKIN status.
Results Thirty-six patients were included. No patients met the AKIN criteria for AKI preoperatively. Postoperatively, 19 patients (53%) met the AKIN criteria for AKI diagnosis: 13 (36%) stage 1, 5 (14%) stage 2, and 1 (3%) stage 3. None required renal replacement therapy. At the 24-hour time points, patients who met the AKIN criteria for AKI had a statistically significantly higher [TIMP-2*IGFBP7] values than the patients without AKI (1.1 vs. 0.27 [ng/mL]2/1,000) at 24 hours (adj-p = 0.0019).
Conclusion AKI is a serious complication associated with adverse outcomes in patients undergoing cardiac surgery. [TIMP-2*IGFBP-7] urinary level 24 hours after CPB is a good predictor of AKI in this population.
Keywordstissue inhibitor of metalloproteinase-2 - insulin-like growth factor binding proteins - acute kidney injury - heart defects, congenital - cardiopulmonary bypass - biomarkers
Received: 14 August 2021
Accepted: 19 October 2021
Article published online:
13 December 2021
© 2021. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
- 1 Blinder JJ, Goldstein SL, Lee VV. et al. Congenital heart surgery in infants: effects of acute kidney injury on outcomes. J Thorac Cardiovasc Surg 2012; 143 (02) 368-374
- 2 Kumar TK, Allen Ccp J, Spentzas Md T. et al. Acute kidney injury following cardiac surgery in neonates and young infants: experience of a single center using novel perioperative strategies. World J Pediatr Congenit Heart Surg 2016; 7 (04) 460-466
- 3 Morgan CJ, Zappitelli M, Robertson CM. et al; Western Canadian Complex Pediatric Therapies Follow-Up Group. Risk factors for and outcomes of acute kidney injury in neonates undergoing complex cardiac surgery. J Pediatr 2013; 162 (01) 120-7.e1
- 4 Lassnigg A, Schmidlin D, Mouhieddine M. et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 2004; 15 (06) 1597-1605
- 5 Zappitelli M, Bernier PL, Saczkowski RS. et al. A small post-operative rise in serum creatinine predicts acute kidney injury in children undergoing cardiac surgery. Kidney Int 2009; 76 (08) 885-892
- 6 Lok CE, Austin PC, Wang H, Tu JV. Impact of renal insufficiency on short- and long-term outcomes after cardiac surgery. Am Heart J 2004; 148 (03) 430-438
- 7 Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 1998; 104 (04) 343-348
- 8 Li S, Krawczeski CD, Zappitelli M. et al; TRIBE-AKI Consortium. Incidence, risk factors, and outcomes of acute kidney injury after pediatric cardiac surgery: a prospective multicenter study. Crit Care Med 2011; 39 (06) 1493-1499
- 9 Fischer MJ, Brimhall BB, Lezotte DC, Glazner JE, Parikh CR. Uncomplicated acute renal failure and hospital resource utilization: a retrospective multicenter analysis. Am J Kidney Dis 2005; 46 (06) 1049-1057
- 10 Bellomo R, Kellum JA, Ronco C. Defining acute renal failure: physiological principles. Intensive Care Med 2004; 30 (01) 33-37
- 11 Kandasamy Y, Rudd D. Cystatin C: a more reliable biomarker of renal function in young infants? A longitudinal cohort study. Acta Paediatr 2021; 110 (04) 1341-1345
- 12 Bihorac A, Chawla LS, Shaw AD. et al. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med 2014; 189 (08) 932-939
- 13 Kashani K, Al-Khafaji A, Ardiles T. et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 2013; 17 (01) R25
- 14 Hoste EA, McCullough PA, Kashani K. et al; Sapphire Investigators. Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers. Nephrol Dial Transplant 2014; 29 (11) 2054-2061
- 15 Gunnerson KJ, Shaw AD, Chawla LS. et al; Sapphire Topaz investigators. TIMP2•IGFBP7 biomarker panel accurately predicts acute kidney injury in high-risk surgical patients. J Trauma Acute Care Surg 2016; 80 (02) 243-249
- 16 Westhoff JH, Tönshoff B, Waldherr S. et al. Urinary tissue inhibitor of metalloproteinase-2 (TIMP-2) • insulin-like growth factor-binding protein 7 (IGFBP7) predicts adverse outcome in pediatric acute kidney injury. PLoS One 2015; 10 (11) e0143628
- 17 Oezkur M, Magyar A, Thomas P. et al. TIMP-2*IGFBP7 (Nephrocheck®) measurements at intensive care unit admission after cardiac surgery are predictive for acute kidney injury within 48 hours. Kidney Blood Press Res 2017; 42 (03) 456-467
- 18 Wetz AJ, Richardt EM, Wand S. et al. Quantification of urinary TIMP-2 and IGFBP-7: an adequate diagnostic test to predict acute kidney injury after cardiac surgery?. Crit Care 2015; 19 (01) 3
- 19 Bojan M, Pieroni L, Semeraro M, Froissart M. Cell-cycle arrest biomarkers: usefulness for cardiac surgery-related acute kidney injury in neonates and infants. Pediatr Crit Care Med 2020; 21 (06) 563-570
- 20 Charlton JR, Boohaker L, Askenazi D. et al; Neonatal Kidney Collaborative. Incidence and risk factors of early onset neonatal AKI. Clin J Am Soc Nephrol 2019; 14 (02) 184-195
- 21 Engelman DT, Ben Ali W, Williams JB. et al. Guidelines for perioperative care in cardiac surgery: enhanced recovery after surgery society recommendations. JAMA Surg 2019; 154 (08) 755-766
- 22 Meersch M, Schmidt C, Hoffmeier A. et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med 2017; 43 (11) 1551-1561
- 23 Katz N, Ronco C. Acute kidney stress–a useful term based on evolution in the understanding of acute kidney injury. Crit Care 2016; 20: 23
- 24 Gomez H, Ince C, De Backer D. et al. A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock 2014; 41 (01) 3-11
- 25 Yang L, Besschetnova TY, Brooks CR, Shah JV, Bonventre JV. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 2010; 16 (05) 535-543 , 1p, 143
- 26 Mehta RL, Kellum JA, Shah SV. et al; Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11 (02) R31
- 27 Kupferman JC, Yitayew M, Rastogi S. Acute kidney injury in term neonates. Curr Treat Options Pediatr 2018; 4: 386-403